Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | PRKCA | P17252 | 1/20 | 0.50 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.50 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.50 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30104624 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL30104654 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL19821495 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL18206768 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL19931336 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL465547 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL19821494 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL465548 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL454068 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM | |
| SCHEMBL30104676 | 1.00 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329638-B2 | Antibacterial agent based on fatty acid esters of hydroxy carboxylic acids | PURAC BIOCHEM B.V. (NL) | 2012-12-11 | — | — | US | claimed |
| US-20110230395-A1 | Antibacterial agent based on fatty acid esters of hydroxy carboxylic acids | PURAC BIOCHEM B.V. (NL) | 2011-09-22 | — | — | US | claimed |
| EP-2200433-B1 | NEW ANTIBACTERIAL AGENT BASED ON FATTY ACID ESTERS OF HYDROXY CARBOXYLIC ACIDS | PURAC BIOCHEM BV (NL) | 2011-07-20 | — | — | EP | claimed |
| US-7973006-B2 | Antibacterial agent based on fatty acid esters of hydroxy carboxylic acid acids | PURAC BIOCHEM B.V. (NL) | 2011-07-05 | — | — | US | claimed |
| US-20090082253-A1 | Antibacterial agent based on fatty acid esters of hydroxy carboxylic acid acids | PURAC BIOCHEM B.V. (NL) | 2009-03-26 | — | — | US | claimed |
| EP-2200433-B1 | NEW ANTIBACTERIAL AGENT BASED ON FATTY ACID ESTERS OF HYDROXY CARBOXYLIC ACIDS | PURAC BIOCHEM BV (NL) | 2011-07-20 | — | — | EP | disclosed |
| US-7973006-B2 | Antibacterial agent based on fatty acid esters of hydroxy carboxylic acid acids | PURAC BIOCHEM B.V. (NL) | 2011-07-05 | — | — | US | disclosed |
| US-20090082253-A1 | Antibacterial agent based on fatty acid esters of hydroxy carboxylic acid acids | PURAC BIOCHEM B.V. (NL) | 2009-03-26 | — | — | US | disclosed |
| EP-1342462-B1 | O/W EMULSION COMPOSITION AND METHOD OF PREPARING THE SAME | OTSUKA PHARMA CO LTD (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-6946436-B2 | O/W emulsion composition and method of preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-09-20 | — | — | US | disclosed |
| EP-0793481-B1 | COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES | UNILEVER PLC (GB) | 2004-06-02 | — | — | EP | disclosed |
| US-20040029761-A1 | O/W emulsion composition and method of preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-0573253-B1 | Topical anti-bacterial composition | UNILEVER PLC (GB) | 2001-08-22 | — | — | EP | disclosed |
| EP-0793481-A1 | COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES | UNILEVER PLC (GB) | 1997-09-10 | — | — | EP | disclosed |
| EP-0572271-B1 | Acyl lactylates as antimicrobial actives | UNILEVER PLC (GB) | 1997-01-22 | — | — | EP | disclosed |
| US-5427772-A | Method for enhancing human skin elasticity by applying octanoyl lactylic acid thereto | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1995-06-27 | — | — | US | disclosed |
| US-5427772-A | Method for enhancing human skin elasticity by applying octanoyl lactylic acid thereto | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1995-06-27 | — | — | US | disclosed |
| WO-1995005153-A1 | COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES | UNILEVER PLC (GB) | 1995-02-23 | — | — | WO | disclosed |
| EP-0595528-A2 | Skin cosmetic composition containing lactylates | UNILEVER PLC (GB) | 1994-05-04 | — | — | EP | disclosed |
| EP-0573253-A2 | Topical anti-bacterial composition | UNILEVER PLC (GB) | 1993-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230395-A1 | Antibacterial agent based on fatty acid esters of hydroxy carboxylic acids | FFAR4, LIPA, HDAC7 | LMNA 1666/4885ALDH1A1 3841/4885MAPT 4369/4885 |
| US-20090082253-A1 | Antibacterial agent based on fatty acid esters of hydroxy carboxylic acid acids | ELOVL5, FFAR4, ELOVL6 | LMNA 1665/4885ALDH1A1 4199/4885MAPT 4083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.